UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000008768
Receipt No. R000010306
Official scientific title of the study An randomized comparative study of efficacy and safety between mirtazapine and duloxetine hydrochloride in patients with cancer
Date of disclosure of the study information 2012/08/25
Last modified on 2017/02/27 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study An randomized comparative study of efficacy and safety between mirtazapine and duloxetine hydrochloride in patients with cancer
Title of the study (Brief title) An randomized comparative study of efficacy and safety between mirtazapine and duloxetine hydrochloride in patients
Region
Japan

Condition
Condition Majar depression in cancer patient
Classification by specialty
Psychiatry
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of mirtazapine or duloxetine hydrochloride on the depressive symptoms in patients with cancer.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes Change in HAM-D scores between pretreatment baseline and 6-week treatment
Key secondary outcomes Specific symptoms (pain and nausea)
Adverse events

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation NO
Institution consideration
Blocking
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 antidepressants
Interventions/Control_2 safety
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Age >= 20 years old
2)Possible oral administration
3)Patient with any cancer
4)Male or female. Inpatient or
outpatient.
5)Written informed consent
Key exclusion criteria 1)Brain metastasis confirmed
2)Congnitive impairment
3)Under interferon therapy
4)Bipolar disorder
5)Convulsive disorder or history of convulsive disorder
6)Prior electroconvulsive therapy
7)Dysuria, glaucoma or treatment for elevated intraocular pressure
8)Administration of the monoamine oxidase (MAO) inhibitor within observation period(2 weeks)
9)Hypersensitivity to mirtazapine or duloxetine hydrochloride
10)Pregnancy or lactating woman, woman planning pregnancy
11)Substance or alcohol abuse 180 days prior to administration of investigational drug.
12)Patient ineligible to the study based on investigator's decision.
Target sample size 20

Research contact person
Name of lead principal investigator Nishimura ryouji
Organization Fukuoka University Faculty of Medicine
Division name Department of Psychiarty
Address 7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan
TEL 092-801-1011
Email

Public contact
Name of contact person Matsushita michihiko
Organization Fukuoka University Faculty of Medicine
Division name Department of Psychiarty
Address 7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan
TEL 092-801-1011
Homepage URL
Email matsushita@fukuoka-u.ac.jp

Sponsor
Institute Fukuoka University Faculty of Medicine Department of Psychiarty
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 福岡大学病院(福岡県)

Other administrative information
Date of disclosure of the study information
2012 Year 08 Month 25 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2012 Year 05 Month 23 Day
Anticipated trial start date
2012 Year 08 Month 25 Day
Last follow-up date
2013 Year 04 Month 01 Day
Date of closure to data entry
2013 Year 09 Month 01 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 08 Month 25 Day
Last modified on
2017 Year 02 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010306